Cite
Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson's disease: An approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies.
MLA
Tripathi, Pratigya, et al. “Identification of Novel Glucocerebrosidase Chaperone for Potential Treatment of Parkinson’s Disease: An Approach Using in Silico Virtual Screening, Molecular Docking and Molecular Dynamics, and in Vitro Studies.” International Journal of Biological Macromolecules, vol. 228, Feb. 2023, pp. 453–66. EBSCOhost, https://doi.org/10.1016/j.ijbiomac.2022.12.217.
APA
Tripathi, P., Ganeshpurkar, A., Singh, S. K., & Krishnamurthy, S. (2023). Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson’s disease: An approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies. International Journal of Biological Macromolecules, 228, 453–466. https://doi.org/10.1016/j.ijbiomac.2022.12.217
Chicago
Tripathi, Pratigya, Ankit Ganeshpurkar, Sushil Kumar Singh, and Sairam Krishnamurthy. 2023. “Identification of Novel Glucocerebrosidase Chaperone for Potential Treatment of Parkinson’s Disease: An Approach Using in Silico Virtual Screening, Molecular Docking and Molecular Dynamics, and in Vitro Studies.” International Journal of Biological Macromolecules 228 (February): 453–66. doi:10.1016/j.ijbiomac.2022.12.217.